ClinicalTrials.Veeva

Menu

Registry for Severe ROP and Treatment on Visual Outcomes

P

Pediatrix

Status

Completed

Conditions

Retinopathy of Prematurity

Study type

Observational

Funder types

Other

Identifiers

NCT01559571
PDX-01-011

Details and patient eligibility

About

The purpose of this study is to determine what factors influence the visual outcomes of infants with severe retinopathy of prematurity (ROP) and to monitor the outcomes.

Enrollment

324 patients

Sex

All

Ages

Under 7 days old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Documentation of informed consent and authorization
  • Inborn and those admitted within 7 days of birth
  • Infant with a diagnosis of stage 2 ROP or higher
  • Site ability to plan close ophthalmological follow-up due to significant and persistent ROP
  • Parents must agree to report outcomes following each ophthalmological visit and overall outcomes for up to five (5) years of age
  • Ability to obtain follow-up data on outcomes if the child is transferred to another facility
  • No known major congenital anomalies

Exclusion criteria

  • ROP stage 1 or less
  • Parents unwilling to participate in follow-up
  • Major congenital anomalies

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems